Rafnar, et al.
A Genome-wide significant association between a sequence variant at 15q15.2 and lung cancer risk.
Cancer Research. 2011. 71, 1356-1361.

Rafnar T, et al.
European Genome-Wide Association Study Identifies SLC14A1 as a New Urinary Bladder Cancer Susceptibility Gene.
Human Molecular Genetics. 2011. 20, 4268-81

Rafnar T, et al.
Mutations in BRIP1/FANCJ confer high risk of ovarian cancer.
Nature genetics. 2011. 43, 1104-7

Rothman N, et al.
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci.
Nature genetics 2010. 42, 978-84

Gudmundsson J, et al.
Genetic correction of PSA values using sequence variants associated with PSA levels.
Science Translational Medicine 2. 2010. (62), 62ra92

Stacey SN, et al.
Ancestry-shift refinement mapping of the C6orf97-ESR breast cancer susceptibility locus. .
PLoS Genet. 2010 Jul 22;6(7):e1001029.

Kiemeney LA, et al.
A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer. .
Nat Genet. 2010 May;42(5):415-9. Epub 2010 Mar 28.

Gudmundsson J, et al.
Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.
Nat Genet. 2009 Oct;41(10):1122-6. Epub 2009 Sep 20.

Kong A, et al.
Parental origin of sequence variants associated with complex diseases. .
Nature. 2009 Dec 17;462(7275):868-74.